© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The safety trial will enroll pregnant women in several sub-Saharan African nations.
A recent study found that the antiretroviral-containing ring was safe and that the girls in the trial used it well.
NIAID research will build on the ASPIRE trials. Those findings showed that dapivirine rings provided “modest” HIV protection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
